Global America Injectable drugs Market Outlook
Global America injectable drugs Market Outlook 2024: Global Opportunity & Growth Analysis, 2016-2024
Report Code :HC 1324
+1-646-568-7747 +1-437-886-1181 +44-203-318-6627 +91-120-473-0422, +91-991-071-6331 sales@goldsteinresearch .com
99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India
www.goldsteinresearch.com
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Global America Injectable drugs Market Outlook Global America injectable drugs Market Size USD (Billion). 2016-2024
Global America injectable drugs Market Share (%), By Countries -2016-2024
XX
XX%
XX
CAGR: (2016-2024)
XX XX
XX
XX
Sample Report
XX
XX
20.00 %
15.0 0%
XX
e l p 2024
2016
85.0 0%
m a S
80.00 %
United States
2016
2017
2018
2019
Source: Goldstein Research
2020
2021
2022
2023
2024
Canada
Source: Goldstein Research
Complex Biologics
In 2016, accounted for the highest market share XX% in Global America injectable drugs Market
Global America injectable drugs Market Share (%), By Product Type-2016
United States
With XX% share by 2024, will dominate the Global America injectable drugs Market
Global America injectable drugs Market Share (%), By Application -2016
14.45%
35.55%
XX% XX%
XX%
XX% 21.48%
XX% XX% XX%
28.52%
Vaccines Complex Biologics
Insulin
Conventional Therapeutics
Source: Goldstein Research
Copyright
All Rights Reserved, Goldstein Research
Cancer
Diabetes
Cardiovascular Diseases
CNS
Infections
Others
Source: Goldstein Research
www.goldsteinresearch.com
Musculoskeletal
Global America injectable drugs Market Outlook
Global America injectable drugs market is anticipated to reach USD XX billion by 2024 from value USD XX billion in 2016, growing at a CAGR of XX% during the forecast period of 2016 to 2024 owing to rising number of patients affected with chronic disease such as cancer and diabetes
On the basis of market players, in the US, Pfizer leads in sales revenues of about USD XX billion USD in 2013 while Johnson & Johnson realized a revenue of USD XX million USD in 2015. In Switzerland, Novartis made USD XX million in revenues in 2014 while Roche realized USD XX million USD in the same year. In France, Sanofi made USD XX million USD in 2014 while in Japan, Takeda made USD XX million USD in 2014. Bayer in Germany made USD XX million USD in 2014 in pharmaceuticals.
e l p
In North America, the most vibrant domestic pharmaceutical market would be found and represents a burgeoning local pharma production industry owing to a protectionist regime as yet. But despite the flourish in local production, the rising consumer demand has led to increasing multinational pharma firms’ interest. Here, the regulatory environment is typified by tough entry barriers largely to protect local industry, price controls, parallel imports and the constant impact of fluctuations in economic conditions
m a S
Although much effort has been put into making injectable drug delivery a better experience for patients, the problem remains that most devices are unable to deliver the drug to just the targeted organ and not throughout the whole body. BeloGal, a latest technology which allows drugs to be delivered in high doses to the right organ and avoids the problems of low water solubility that hamper many modern formulations
The drug delivery industry is focused on finding ways to enhance the injection experience, i.e. make it more pleasant for the patient, from helpful reminders, self-use devices, connecting to smartphones, making the syringes larger or smaller and containers gentler and smarter.
Healthcare services shifts from clinical settings to the home
Medical benefits and reimbursemen t policies
Rise in diabetic population
Advancement in pharmaceuticals & cost containment
Global America injectable drugs Market Size (USD Billion), By Country, 2016-2024
Copyright
Year
United States
2016
XX Million
XX Million
2024
XX Million
XX Million
All Rights Reserved, Goldstein Research
Canada
www.goldsteinresearch.com
Global America injectable drugs Market Outlook : 2016-2024 Global America injectable drugs Y-O-Y Growth (%) Analysis-2016-2024
Global America injectable drugs Market Size (USD Billion)-2016-2024 XX
XX
XX%
XX
XX%
XX
XX%
XX
XX XX
XX%XX% XX% XX%XX%XX% XX% XX%XX% XX%
XX
XX
XX%
XX XX
XX XX
e l p XX%
XX
XX
XX
Sample Report
XX%
XX
XX%
XX
XX% XX%
XX
XX%
XX
m a S
2016 2017 2018 2019 2020 2021 2022 2023 2024
Source: Goldstein Research
2016
2017
2018
2019
2020
2021
2022
2023
2024
Source: Goldstein Research
Table.1. Global Sales (USD Billion) of Injectable Drugs, By Product Type, 2016-2024
Product Type/Year
2016
2017
2018
2019
2020
2021
2022
2023
2024
CAGR %
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX%
Insulin
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX%
Conventional Therapeutics
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX%
Complex Biologics
XX
XX
XX
XX
XX
XX
XX
XX
XX
XX%
Vaccines
Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Fertile Market of Sterile Injectables Sterile Biologics Market Share (%), By Type, 2016
The global sterile Injectable market is USD XX billion in 2016 and is projected to Albumin; XXUSD XX billion by 2024. The two reach Fusion Proteins; XX% largest segments are Biologics (XX% share) % Blood and Small Molecule injectables (XX% MAbs; XX% Factors; XX% share), with a CAGR of XX% for the latter. Immunoglo Within Biologics, monoclonal antibodies bin; XX% (mAbs) account for the largest market Vaccines; XX share, followed by vaccines and insulin. In % the Small Molecule segment, Oncology Cytokines; XX% and Anti-Infectives are the major Peptide contributors of the market. Hormones; Source: Goldstein Research
XX%
m a S Insulin; XX%
What Is Driving Sterile Injectables Market?
e l p
Approximately XX injectable products are currently in the development pipeline (potent and nonpotent), leading to growth on the innovative side of the market. Demand for cutting edge injectable capabilities should grow as ADCs and other high value products dominate the ‘potent’ development space. Nevertheless, the primary driver behind the growth in injectables is the generic market. Growth in the generic injectables is outpacing growth on the innovator side: The global, generic, sterile injectables market is projected to grow from USD XX billion in 2016 to USD XX billion in 2024 – at a growth rate of XX%. Global America injectable drugs Market Demand-supply Equation Number of Sterile Injectables Drugs In Short Supply, 2014-2016 XX XX
XX
XX
XX
XX
XX XX XX XX XX XX XX 2014
Source: Goldstein Research
2015
2016
The development and manufacturing of sterile injectable products is both, complex, and capital intensive. Operational costs are high since injectables are toxic and infectious in their natural state and hence require a higher degree of quality and care in their manufacturing, packaging, storage, and distribution. Stringent regulations from FDA on manufacturing sites, pose a major challenge for both existing players, and for potential new market entrants.
Competition from low cost manufacturing zones like India and China in the generic market has led to discontinuation of many products in the segment for economies of scale. Consolidation of captive/in-house manufacturing capacities have resulted in closure of many sterile manufacturing sites in the US and elsewhere which, in turn has led to product shortages in the US. Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Global America injectable drugs Market Outlook : 2016-2024 US Injectable Drugs market accounted for USD XX billion in 2016 which tends to increase at a CAGR of XX% over the forecast years and reach the valuation of USD XX billion by 2024
Global America injectable drugs Market Share, By Product Type, 2016-2024 Vaccines 14.45%
36.00%
Insulin
35.55% 21.48%
28.52%
14.00%
e l p
The increase focus in biologics and targeted therapies, especially in the area of cancer has led to an increase in the need for injectable drugs. While biological drugs have a larger part of the injectable market, the small molecule injectable will have the higher growth
21.00% Conventional Therapeutics
29.00%
Complex Biologics
m a S
The complex process of manufacture, high capital and Global America injectable drugs Market Y-O-Y Growth, By Product operational costs, and the Type- 2016-2024 compliance requirements for success has led to a smaller number XX% of players. These rms are being XX% further reduced due to acquisitive XX% activity in a sector that is rapidly consolidating. The supply crunch XX% that was present a few years ago XX% has been mitigated to some extent XX% by FDA actions Source: Goldstein Research
XX% XX% 2016e
2017f
2018f
Source: Goldstein Research
2019f
2020f
2021f
2022f
2023f
2024f
Global America injectable drugs Market Size (USD Billion), By Application-2016-2024 XX XX
XX XX XX
494.00 XX% 360.00 %
XX XX
2016 Diabetes
Cancer
907.00 % 665.00 %
2024 Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Source: Goldstein Research
Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Others
Global America injectable drugs Attractiveness-By Country, 2016-2024
Market
Global America injectable drugs Market Attractiveness-By Country, 2016-2024 XX
Canada
United States
Sample Report
XX
CAGR (%)
XX
XX
XX
XX XX
Source: Goldstein Research
XX
XX
e l p m XX
XX
XX
Market Size (USD Billion)
According to the above graph, U.S. Injectable Drugs market is anticipated to be the most attractive market across all the countries in injectable drugs market, for new entrants looking to enter in the market, existing players looking for business expansion and investors seeking investment opportunities over the forecast period i.e. 2016-2024
a S
Canada's single-payer system is mostly publicly funded, while the U.S. has a multi-payer, heavily private system. While dissatisfaction with the U.S. health care system is widespread among Americans, Canada's health care system enjoys high levels of satisfaction among its own population therefore in forecast period Canada tends to reach the considerable market size of injectable drugs
Download Exclusive Sample Report:
https://www.goldsteinresearch.com/request-sample/global-injectable-drugs-market-outlook -2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024
Source: Goldstein Research
Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
XX
Global America injectable drugs Market Outlook Sample Report
About us Connect With Us:
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
About Us
Sample Report
Based in U.S., Goldstein Research is a young business consulting and market research firm with vast reach across America, Asia and parts of Europe and the Middle East. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
With 30+ domain experts and 50+
employees working day and night to crunch numbers and bring out the best and detailed market reports and forecasts, we strive to enable you to foresee upcoming market challenges and develop a robust business model and strategies, which would add to your profitability and market visibility as a brand. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts.
Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Vision
Value
Visibility
Contact Us: For Research & Sales Related Queries +1-646-568-7747 +1-437-886-1181 +44-203-318-6627 +91-120-473-0422 +91-991-071-6331 sales@goldsteinresearch.com
Corporate Office: 99 Wall Street, Suite No:527, New York, NY 10005 United States of America
Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India www.goldsteinresearch.com
Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com
Global America injectable drugs Market Outlook
Sample Report
thAnk you Connect With Us:
Published By: Goldstein Research Copyright
All Rights Reserved, Goldstein Research
www.goldsteinresearch.com